These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 19877067)

  • 21. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
    Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
    Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombocytosis in a macrophage activation syndrome complicating systemic lupus erythematosus].
    Lekpa FK; Ndongo S; Fall S; Pouye A; Ka MM; Moreira-Diop T
    Pan Afr Med J; 2014; 19():11. PubMed ID: 25584123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.
    Avcin T; Tse SM; Schneider R; Ngan B; Silverman ED
    J Pediatr; 2006 May; 148(5):683-6. PubMed ID: 16737887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus.
    Gutiérrez-Suárez R; Ruperto N; Gastaldi R; Pistorio A; Felici E; Burgos-Vargas R; Martini A; Ravelli A
    Arthritis Rheum; 2006 Sep; 54(9):2989-96. PubMed ID: 16947634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood.
    Brunner HI; Freedman M; Silverman ED
    Arthritis Rheum; 1999 Nov; 42(11):2346-55. PubMed ID: 10555030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Macrophage activation syndrome: report on three cases].
    Zietkiewicz M; Hajduk A; Wojteczek A; Smoleńska Z; Czuszyńska Z; Zdrojewski Z
    Ann Acad Med Stetin; 2012; 58(1):55-61. PubMed ID: 23547396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

  • 29. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
    Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
    Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of juvenile lupus erythematosus in Iranian children.
    Moradinejad MH; Zamani GR; Kiani AR; Esfahani T
    Acta Reumatol Port; 2008; 33(1):63-7. PubMed ID: 18344923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of macrophage activation syndrome successfully treated with anakinra.
    Kelly A; Ramanan AV
    Nat Clin Pract Rheumatol; 2008 Nov; 4(11):615-20. PubMed ID: 18825135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.
    Fall N; Barnes M; Thornton S; Luyrink L; Olson J; Ilowite NT; Gottlieb BS; Griffin T; Sherry DD; Thompson S; Glass DN; Colbert RA; Grom AA
    Arthritis Rheum; 2007 Nov; 56(11):3793-804. PubMed ID: 17968951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
    Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
    Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical importance of lymphadenopathy in systemic lupus erythematosus.
    Melikoglu MA; Melikoglu M
    Acta Reumatol Port; 2008; 33(4):402-6. PubMed ID: 19107085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
    Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
    Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set.
    Ruperto N; Ravelli A; Cuttica R; Espada G; Ozen S; Porras O; Sztajnbok F; Falcini F; Kasapcopur O; Venning H; Bica B; Merino R; Coto C; Ros J; Susic G; Gamir ML; Minden K; See Y; Uziel Y; Mukamel M; Riley P; Zulian F; Olivieri AN; Cimaz R; Girschick H; Rumba I; Cavuto S; Pistorio A; Lovell DJ; Martini A; ;
    Arthritis Rheum; 2005 Sep; 52(9):2854-64. PubMed ID: 16142708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.